Twice-yearly oral doses of azithromycin reduce the incidence of potentially blinding trachoma and the incidence of overall death in children in West Africa. However, new data analysis suggests that the favorable effect of azithromycin is limited to children without ready access to healthcare.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.